This company seems to have been delisted
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Albireo Pharma
ALBO
38,09 €
Share price
0.00%
Change (1 day)
104.31%
Change (1 year)
Categories
Market capitalization of Albireo Pharma (ALBO)
Last known market cap: €0.79 Billion
On May 5, 2023 Albireo Pharma had a market cap of €0.79 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Albireo Pharma from 2007 to 2023
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2023 | €0.82 B | 98.66% |
| 2022 | €0.41 B | 5.09% |
| 2021 | €0.39 B | -31.9% |
| 2020 | €0.58 B | 101.41% |
| 2019 | €0.28 B | 12.72% |
| 2018 | €0.25 B | 35.17% |
| 2017 | €0.18 B | 79.01% |
| 2016 | €0.10 B | 427.71% |
| 2015 | €20.09 M | -21.63% |
| 2014 | €25.64 M | -26.27% |
| 2013 | €34.78 M | 38.12% |
| 2012 | €25.18 M | 38.52% |
| 2011 | €18.18 M | -50% |
| 2010 | €36.36 M | -49.73% |
| 2009 | €72.34 M | -11.51% |
| 2008 | €81.75 M | -74.66% |
| 2007 | €0.32 B |
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | €0.84 B | 6.44% | 🇺🇸 USA |